Asia Pacific Poultry Vaccines Market Size, Share, Growth, Trends, Industry Analysis: By Vaccine Type, By Formulation Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application, and Country Forecast 2020-2031
Asia Pacific Poultry Vaccines Market size was valued at US$ 821.15 million in 2024 and is expected to reach US$ 1510.76 million by 2031, growing at a significant CAGR of 9.1% from 2025-2031. Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Mareks disease, Newcastle disease, and infectious diseases among others. Rise in population demand for healthy meat and poultry products, increase in R&D activities for the innovation newer poultry vaccines, government initiations such as organizing vaccination programs to protect the animal health, increase in the poultry production, and increase in the number of poultry farms are expected to boost the Asia Pacific poultry vaccines market over the forecast period.
stringent regulatory guidelines for vaccine approvals, poor awareness about the poultry vaccination, and high cost of vaccines may hamper the growth of Asia Pacific poultry vaccines market in forthcoming years.
Asia Pacific poultry vaccines market is segmented into Japan, China, India, Australia & New Zealand, ASEAN Countries, South Korea, and Rest of Asia Pacific. Japan poultry vaccines market driven by increase in R&D activities for the innovation of newer vaccines, growth in veterinary healthcare expenditure, and rise in prevalence of infectious diseases such as bird flu are expected to bolster the market. China poultry vaccines market has a prominent growth rate, which is attributed to increase in the adoption of newer vaccines, rise in trading of poultry and poultry products, and collaboration between the companies are propel the market. India poultry vaccines market has a significant share in global market owing to government support for the poultry production, increase in exportation of poultry and poultry products to Oman, Germany, Indonesia, Saudi Arabia, and Afghanisthan, and increase in awareness about poultry diseases are fuel the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 821.15 million |
|
Market Size in 2031 |
US$ 1510.76 million |
|
By Vaccine Type |
|
|
By Formulation |
|
|
By Application |
|
Download Free Sample Report
Asia Pacific poultry vaccines market size was valued at US$ 821.15 million in 2024 and is expected to reach US$ 1510.76 million by 2031, growing at a significant CAGR of 9.1% from 2025-2031.
The report covers China, India, Japan, Australia & New Zealand
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2. Asia Pacific Poultry Vaccines Market Introduction |
| 2.1. Asia Pacific Poultry Vaccines Market - Taxonomy |
| 2.2. Asia Pacific Poultry Vaccines Market - Definitions |
| 2.2.1.Vaccine Type |
| 2.2.2.Formulation |
| 2.2.3.Application |
| 2.2.4.Country |
| 3. Asia Pacific Poultry Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Asia Pacific Poultry Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Asia Pacific Poultry Vaccines Market By Vaccine Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Live Attenuated Vaccines |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Recombinant Vaccines |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Asia Pacific Poultry Vaccines Market By Formulation, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Dry Form (Duct) Vaccines |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Liquid Vaccines |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Freeze Dried Vaccines |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Asia Pacific Poultry Vaccines Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Marek’s Disease |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Newcastle Disease |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Infectious Bursal Disease |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Infectious Bronchitis |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Asia Pacific Poultry Vaccines Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. China |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. India |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Australia and New Zealand (ANZ) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Japan |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Rest of APAC |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Competition Landscape |
| 9.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 9.2.1.Zoetis (Pfizer, Inc.) |
| 9.2.2.Merck & Co. Inc. |
| 9.2.3.Boehringer Ingelheim Vetmedica |
| 9.2.4.Elanco |
| 9.2.5.Bayer Animal Health |
| 9.2.6.Ceva Sante Animale |
| 9.2.7.Zydus AHL |
| 9.2.8.Indovax Pvt. Ltd. |
| 9.2.9.Hester Biosciences Limited. |
| 10. Research Methodology |
| 11. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Sample
